Evaluation of oxaliplatin and tigio combination therapy in locally advanced gastric cancer

Table 1 Comparison of clinical data between the two groups

Index	Study group (n = 45)	Control group (n = 45)	χ2/t	P value
Sex			0.044	0.832
Male	25	24
Female	20	21
Age (yr)	48.80 ± 9.50	49.50 ± 9.80	0.639	0.524
BMI (kg/m2)	23.50 ± 3.12	24.01 ± 2.85	0.796	0.427
Complications (n)			0.795	0.672
Diabetes	4	5
Hypertension	18	14
Hyperlipidemia	9	11
Arrhythmia	2	1
Smoking history (n)			0.189	0.664
Yes	16	18
No	29	27
Drinking history (n)			0.179	0.673
Yes	20	22
No	25	23

BMI: Body mass index.